Terug
Dagbereik
€ 31,39
€ 32,44
52-Weeksbereik
€ 14,40
€ 32,44
Volume
641.526
50D / 200D Gem.
€ 26,77
/
€ 24,92
Vorige Slotkoers
€ 31,19
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -8,2 | 0,3 |
| P/B | 4,0 | 3,0 |
| ROE % | -40,6 | 3,7 |
| Net Margin % | -17253,3 | 3,8 |
| Rev Growth 5Y % | -24,6 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 24,00
-24.2%
Forward WPA
-€ 4,83
Omzet Sch.
2,63M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 4,15
-€ 0,43 – € 12,49
|
890,91M | 3 |
| FY2029 |
-€ 0,16
-€ 0,47 – € 0,02
|
471,29M | 3 |
| FY2028 |
-€ 3,63
-€ 5,17 – -€ 1,55
|
126,54M | 9 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | -€ 1,02 | -€ 1,22 | -19,3% |
| 2025-11-10 | -€ 0,88 | -€ 1,01 | -14,8% |
| 2025-08-07 | -€ 0,86 | -€ 0,85 | +1,2% |
| 2025-05-08 | -€ 0,75 | -€ 0,81 | -8,0% |
| 2025-02-27 | -€ 0,73 | -€ 0,71 | +2,7% |
| 2024-11-06 | -€ 0,69 | -€ 0,64 | +7,2% |
| 2024-08-08 | -€ 0,59 | -€ 0,54 | +8,5% |
| 2024-05-06 | -€ 0,67 | -€ 0,56 | +16,4% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue declined -24,64% annually over 5 years
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -213,66M
Revenue growth is decelerating — 1Y growth trails 5Y average by 53,99%
Capital intensive — 180,93% of revenue goes to capex
Groei
Revenue Growth (5Y)
-24,64%
Revenue (1Y)-78,63%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-40,62%
ROIC-40,71%
Net Margin-17253,33%
Op. Margin-19160,00%
Veiligheid
Debt / Equity
0,00
Current Ratio10,49
Interest Coverage0,00
Waardering
P/E Ratio
-8,15
Forward P/EN/A
P/B Ratio4,00
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -78,63% | Revenue Growth (3Y) | -53,32% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -24,64% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,50M | Net Income (TTM) | -258,80M |
| ROE | -40,62% | ROA | -44,39% |
| Gross Margin | 100,00% | Operating Margin | -19160,00% |
| Net Margin | -17253,33% | Free Cash Flow (TTM) | -213,66M |
| ROIC | -40,71% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 10,49 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8,15 | Forward P/E | N/A |
| P/B Ratio | 4,00 | P/S Ratio | 1405,88 |
| PEG Ratio | -0,12 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 801,22 | Fwd Earnings Yield | N/A |
| FCF Yield | -10,13% | ||
| Market Cap | 2,11B | Enterprise Value | 2,08B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,50M | 7,02M | 6,88M | 2,36M | 4,65M |
| Net Income | -258,80M | -157,86M | -141,43M | -112,33M | -70,51M |
| EPS (Diluted) | -3,90 | -2,45 | -2,92 | -2,40 | -1,64 |
| Gross Profit | 1,50M | -156,53M | -111,13M | -79,90M | -48,66M |
| Operating Income | -287,40M | -195,08M | -154,54M | -115,23M | -71,24M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 582,98M | 792,34M | 465,63M | 352,74M | 444,65M |
| Total Liabilities | 55,82M | 45,34M | 36,46M | 26,53M | 25,18M |
| Shareholders' Equity | 527,17M | 747,01M | 429,17M | 326,20M | 419,48M |
| Total Debt | 2,34M | 3,81M | 2,54M | 4,03M | 3,04M |
| Cash & Equivalents | 28,87M | 28,36M | 34,81M | 29,43M | 39,14M |
| Current Assets | 534,66M | 747,16M | 431,69M | 317,69M | 410,84M |
| Current Liabilities | 50,99M | 39,50M | 31,13M | 18,61M | 16,53M |